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Burkholderia cepacia isolates from patients with cystic fibrosis (CF) attending five CF centers were 
studied for relatedness by cellular fatty acid methyl esters (FAME) and by chromosomal DNA 
restriction analysis. Twenty-eight of 32 (87.5%) isolates tested were grouped in cluster group 1 based on 
their FAME profiles. DNA analysis revealed that 29 of 32 (90.6%) B. cepacia isolates from five CF 
centers had one closely related DNA pattern. To examine strain variation over a time period, FAME 
profiles and DNA patterns of isolates from serial cultures on seven patients from center D were studied. 
For four patients, all serial B. cepacia isolates belonged to a single FAME cluster group; for the 
remaining three patients, all serial isolates belonged to any two of the four cluster groups. On serial 
culture isolates, a single DNA pattern (pattern A) was found in 31 of 32 isolates demonstrating a close 
genetic relatedness. 
These data corroborate the observations that the majority of patients colonised with B. cepacia in a 
CF center harbor strains genetically closely related as determined by FAME profiles and DNA patterns. 
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Introduction 
Burkholderia (Pseudomonas) cepacia colonisation/ 
infection of the respiratory tract of patients with 
cystic fibrosis (CF) has been associated with increased 
morbidity and mortality (1). There has also been 
concern regarding patient-to-patient or common 
environmental transmission of B. cepacia, especially, 
in view of clustering of colonised patients at some 
tertiary health-care CF centers (2-7). Epidemiology 
of B. cepacia infections remains poorly defined 
because of the paucity of accurate methods estab- 
lished for B. cepacia strain differentiation (8). Inves- 
tigators have utilised principal cell wall fatty acid 
content, DNA chromosomal analysis and ribotyping 
to distinguish B. cepacia strains (9-19). 
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The isolates of B. cepacia from five CF centers in 
the State of Michigan, U.S.A., located at Ann Arbor, 
Detroit, Grand Rapids, Kalamazoo and Lansing, 
were studied. From one of the centers (Lansing), 
isolates collected on serial cultures from patients were 
also studied. The isolates were analysed for bacterial 
cellular fatty acid methyl esters (FAME) by gas liquid 
chromatography. Furthermore, the use of chromo- 
somal DNA restriction endonuclease analysis was 
investigated as an alternative tool to differentiate 
isolates of B. cepacia. 
Materials and Methods 
BACTERIAL ISOLATES 
Burkholderia cepacia isolates from the sputum of 
patients at five CF centers (A-E) in Michigan were 
collected over a 9-month period were submitted to the 
Microbiology Section of the Michigan Department 
of Community Health for study. Isolates from 32 
patients (one isolate per patient) were submitted from 
f(i 1997 W. B. SAUNDERS COMPANY LTD 
486 A. KUMAR ET AL. 
the five centers for this study. In addition, B. cepacia 
isolates from serial cultures (3-6 isolates per patient) 
identified over an 8-month period were also submit- 
ted by center D. The confirmation of B. (Pseudo- 
monas) cepacia was accomplished by performing 
biochemical testing and cellular fatty acid analysis. 
The isolates were first Gram stained and tested for 
oxidase, catalase, motility and growth on Macconkey 
agar. They were then tested with a commercial iden- 
tification system (NFT, Analytab Products Inc.) for 
glucose fermentation argenine dilhydrolase, urease, 
esculin hydrolysis, gelatinase, P-galactosidase and 
assimilation of the following: D-glucose, L-arabinose, 
D-mannose, D-mannitol, N-acetyl-D-glucosamine, 
maltose, D-gluconate, caprate, adipate, L-malate, cit- 
rate and phenyl-acetate. If the results of this testing 
and the cellular fatty acid analysis were consistent 
with known reactions for B. cepacia, the isolate was 
confirmed as such. Discrepant reactions were resolved 
with conventional biochemical testing. Following bio- 
chemical confirmation of identification, the organ- 
isms were frozen in skimmed milk medium at - 70°C 
until further testing. Reference strains of B. cepacia 
(ATCC 13945, 17762 and 17765) served as controls. 
ANALYSIS OF CELLULAR FATTY ACIDS 
Cellular extracts were prepared by the method of 
Lambert and Moss (20). The organic phase was 
further concentrated by evaporation under nitrogen. 
FAME profiles were determined with a Varian chro- 
matograph model 3500 equipped with a 5% phenyl- 
methyl silicone capillary column DB-5 (J & W 
Scientific Folsom, CA, U.S.A.). Fatty acid peaks 
were automatically integrated, identified and percent- 
ages were calculated. The reproducibility of the 
chromatography technique was determined by 
repeated analysis of standard quantitative FAME 
control mixtures. 
ANALYSIS OF CELLULAR FATTY ACIDS DATA 
Peak area values, obtained from the FAME profiles 
of each isolate, were calculated as percentage of the 
total peak area and were used for the analysis. To 
obtain cluster analysis, the sum of total peak area of 
the 16:0, 16: 1 and 17:0 Cyc acids were added together 
to form the fatty acid group alpha. The sum of total 
peak area of the 18:0, 18: 1 (Cis and trans) and 19:0 
Cyc acids were added together to form the fatty acid 
group beta. This grouping strategy is similar to the 
method of Mukwaya and Welch and is based on 
related fatty acids in each group (9). 
STATISTICAL ANALYSIS 
Differences between FAME profiles of B. cepacia 
isolates were calculated by determining resealed dis- 
tance cluster combine utilising dendrograms with 
average linkage on SPSS program. This analysis 
resulted in each isolate falling into one of the four 
cluster groups (14) depending upon the distance, i.e. 
similarities, between the cellular fatty acid content of 
the isolate. 
CHROMOSOMAL DNA RESTRICTION 
ANALYSIS OR DNA FINGERPRINTING BY 
PULSED-FIELD GEL ELECTROPHORESIS (PFGE) 
Chromosomal DNA was prepared from typticase soy 
tryptose broth cultures and digested with XbaI and 
SpeI (Promega Corp, Madison, WI, U.S.A.) in 0.75% 
low melt agarose plugs (FMC Corp, Rockland, MD, 
U.S.A.). Portions of digested plugs were loaded into 
1% agarose gels. Electrophoresis was performed with 
the CHEF DRII system (BioRad Laboratories, 
Hercules, CA, U.S.A.) at 6V/per cm, 14°C for 22 h. 
Multiple gels were run, using various pulse condi- 
tions, to optimally resolve all of the fragments. For 
XbaI, pulse times of 15 and 45 s were used; for SpeI 
35 and 55 s were used. DNA patterns were visualised 
by staining with ethidium bromide, and photo- 
graphed under ultra-violet light. Banding patterns 
from different gels were compared to determine DNA 
relatedness. 
Results 
The five CF centers are spread out within a radius of 
90 miles and are located 30-180 miles from each 
other. Burkholderia cepacia isolates obtained from 
these CF centers were biochemically confirmed as B. 
cepacia. These included four isolates from four 
patients from center A, four isolates from four 
patients from center B, 10 isolates from 10 patients 
from center C, 34 isolates from seven patients from 
center D and seven isolates from seven patients from 
center E. From center D, B. cepacia strains identified 
on serial cultures were available from seven patients; 
B. cepacia isolates were available from six serial 
cultures on two patients, from five serial cultures on 
three patients, from four serial cultures on one patient 
and from three serial cultures on one patient. 
Distribution of B. cepacia isolates based on the 
cluster analysis of the FAME profiles of the group 
alpha and the group beta cellular fatty acids are 
shown in Tables 1 and 2. Table 1 shows distribution 
of all B. cepacia isolates from centers A, B, C and E 
and seven of 34 isolates for center D; the seven 
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TABLE 1. Cluster analysis groups (l-4) based on fatty acid methyl ester (FAME) profile of 
the isolates of Burkholderiu cepaciu from cystic fibrosis (CF) centers in the state of 
Michigan, U.S.A. 
CF 
centers 
Number 
of 
isolates 
Cluster analysis groups based on FAME profile 
1 2 3 4 
A 4 4 0 0 0 
g’ ..I’ 4 4 0 0 0 
C 10 9 1 0 0 
D 7 6 1 0 0 
E 7 5 0 1 1 
Total 32 28 2 1 1 
B. cepacia isolates from center D were the isolates electrophoresis (Table 3). For each isolate examined, 
obtained from patients’ first culture (data on B. digestion with X&I produced 21-25 fragments, of 
cepacia isolates obtained on serial cultures is shown in about 40-500 kilobases; digestion with SpeI produced 
Table 2). Twenty-eight of 32 (8795%) isolates from 16-18 fragments, of about 40-1200 kilobases. DNA 
five centers belonged to cluster group 1; two of 32 was digested by two different enzymes (SpeI, XbaI) 
(6.25%) isolates belonged to cluster group 2 and one and digestion with both enzymes generated patterns 
isolate each from center E belonged to cluster group 3 which were interpreted as comparably similar. Iso- 
and cluster group 4. Between 71 and 100% of the lates were considered to be the same or related strains 
isolates from each center were clustered in cluster if their pulse-field gel electrophoresis patterns were 
group 1. Cluster analysis of the B. cepacia isolates identical or differed by less than three bands. DNA 
obtained from serial cultures of seven patients patterns were identified by letters A, B, C or D and 
revealed four cluster groups (Table 2). All isolates differed from one another by several fragments. 
(3-6 isolates) from a patient belonged to any two of Amongst type A, sub-patterns were further described 
the four cluster groups. Between 80 and 100% of as Al, A2 and A3 which differed by one to three 
those serial isolates on individual patients belonged to bands. Type A subpatterns were considered related 
a single cluster group. but not identical. 
To determine DNA relatedness of B. cepacia 
isolates, isolates were analysed by pulsed-field gel 
Except for the three isolates from center E, all 
other B. cepacia isolates had closely related DNA 
TABLE 2. Cluster analysis based on fatty acid methyl ester (FAME) profiles of Burkholderia 
cepacia isolated on serial cultures from seven patients 
Patient 
no. 
Number 
of 
isolates 
Cluster analysis groups based on FAME profile 
1 2 3 4 
1 6 6 0 0 0 
2 6 6 0 0 0 
3 3 3 0 0 0 
4 5 4 1 0 0 
5 5 5 0 0 0 
6 5 0 1 4 0 
7 4 3 0 0 1 
Total 34 27 2 4 1 
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TABLE 3. Chromosomal DNA restriction endonucle- 
ase digestion patterns with restriction enzyme X&I 
separated by pulsed field gel electrophoresis on Burk- 
holderia cepacia isolates from five cystic fibrosis 
centers (A-E) 
DNA 
patterns 
Total 
(32) 
Al 2 4 4 4 4 18 
A2 2 - 6 2 - 10 
A3 - - - 1 - 1 
B - - - - 2 2 
C - - - - 1 1 
Number of patients from each center are given in 
parentheses. 
patterns. Three B. cepacia isolates from center E were 
classified as DNA patterns B and C (Plate 1 and Fig. 
1). Of the 32 isolates examined, 18 belonged to 
pattern Al, 10 to pattern A2, one to pattern A3, two 
to pattern B and one to pattern C. 
Serial B. cepacia isolates obtained over a period of 
5-8 months, from seven patients from center D 
(Table 4), revealed that isolates from five of seven 
patients belonged to a single pattern (either pattern 
Al, A2 or A3). On patient four, three of five isolates 
obtained on four serial cultures were pattern Al, and 
one isolate demonstrated pattern A3. However, one 
TABLE 4. Chromosomal DNA endonuclease digestion 
patterns of isolates from serial cultures on seven 
patients from center D 
Patient 
no. 
Number of DNA 
cultures pattern 
1 6 A3 (6) 
2 6 Al (6) 
3 3 Al (3) 
4 4* Al (3) 
A3 (1) 
D Cl)* 
5 5 A2 (5) 
6 4* Al (4) 
A2 (l)* 
7 4 A2 (4) 
Number of isolates are given in parentheses. 
*One culture had two morphologically distinct 
Burkholderia cepacia isolates. 
PLATE 1. Pulsed field gel electrophoresis of Burk- 
holderia cepacia DNA digested with XbaI. Pulse 
times of 5-35 s for 20 h. DNA size markers (each 
band is a multiple of 48.5 kb) are shown in Lanes 1 
and 8. Lanes 2-7 show patterns Al, A2, A3, B, C 
and D, respectively. 
isolate from this patient demonstrated pattern D. The 
DNA pattern group D, B. cepacia isolate, was one of 
the two morphologically distinct colonies isolated 
from a single culture. On patient six, four of five 
isolates demonstrated pattern Al. One morphologi- 
cally distinct colony from patient 6 belonged to 
pattern A2. DNA patterns of B. cepacia ATCC 
reference strains were distinct from the patterns of the 
CF patient isolates. Similarly, DNA patterns of four 
environmental B. cepacia isolates (data not shown) 
were distinct from both the patterns of isolates from 
the CF centers and the ATCC reference strains. 
The dendrogram (Fig. 1) which uses complete 
linkage shows resealed distance between isolates on 
cluster analysis based on the FAME profiles of the 
isolate. Two isolates (numbers 29 and 30) from center 
E demonstrated DNA pattern B by PFGE analysis; 
these two isolates were also distinct from other iso- 
lates on their FAME profiles as one belonged to 
cluster group 3 and the other to cluster group 4. 
Figure 2 shows DNA restriction endonuclease diges- 
tion patterns of B. cepacia isolates obtained on serial 
cultures of patients 1-7 from center D and the 
distance between isolates on cluster analysis based on 
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Dendrogram using Average Linkage (Between Groups) 
Resealed Distance Cluster Combine 
Isolate 
NUIll 
CF 
Center I 0 5 10 15 20 25 
I 
DNA I I 
I I , +---------+---------+---------+-----------t------~--t 
A2 c 12 -t 
Al D 21 -t 
C E 31 -t 
Al A 4 -t 
Al D 25 -t 
Al A 3 -t-t 
Al D 22 -+ I 
Al E 27 -+ I 
Al B I -t t-t 
Al B 6 -+ I I 
Al C 11 -+ I I 
Al C 13 -t-t 1 
A2 D 23 -t t-----------t 
A2A 1 -t I I 
Al B 8 -t-t 1 I 
A2c 9 -t t-t 
A2 D 24 -+ I I 
Al B 5 ---t j 
A2 c 15 -t-t 1 
A2 C 16 -+ I I 
A3 D 20 -t +-t t-------------------------------t 
Al E 32 -+ I 
Al E 26 -+ I 
Al C 17 -t-t 
A2A 2 -t 
Al C 14 -t 
A2 C 18 -+ 
Al E 28 -t 
A2 c 10 -t-------t I 
Al D 19 -t +-------+ I 
B E 30 ---------+ I 
B E 29 -------------------------------------------------t 
FIG. 1. Genetic relatedness of Burkholderiu cepacia isolates from five cystic fibrosis centers (A-E) based on 
isolates’ chromosomal DNA restriction endonuclease pattern (DNA). The denodrogram also shows distance 
between 32 B. cepaciu isolates based on bacterial cell wall fatty acid methyl ester (FAME) profile. 
the FAME profiles of these isolates. One isolate (Fig. 
2, isolate number 20) from patient 4 showing DNA 
pattern D on DNA restriction endonuclease analysis 
was not distinct on cluster analysis and had a FAME 
profile which was similar to the FAME profiles of 
DNA pattern A. 
Discussion 
To understand the epidemiology of B. cepacia 
colonisation/infection in patients with CF, investiga- 
tors have utilised a variety of typing techniques 
(9-19). Isolates of B. cepaciu from patients at five CF 
centers in Michigan, located within a radius of 90 
miles, were studied by determining principal cell wall 
fatty acid content by gas liquid chromatography and 
chromosomal macro DNA restriction endonuclease 
digestion analysis. Between 71 and 100% of the 
isolates from each CF center belonged to FAME 
cluster group 1. Approximately 94% (30 of 32) of 
isolates were grouped in FAME cluster groups 1 and 
2. These results corroborate the observations of 
Mukwaya and Welch that the majority of patients 
colonised with B. cepacia harbor strains with the 
same FAME profile (9). DNA restriction endonucle- 
ase digestion revealed that 29 of 32 (90.6%) of B. 
cepacia isolates from five CF centers in Michigan had 
closely related DNA patterns. Unlike other investiga- 
tors, the present authors were not always able to 
attribute minor pattern differences to genetic events 
(22). 
To examine possible strain variation over time, 
serial cultures from seven patients were studied at 
center D. Strain variation was noted as evidenced by 
serial isolates grouping in one of the two cluster 
groups. A single DNA pattern was found in 33 of 34 
490 A.KUMAR ETAL. 
I 
I 
A2 
Al 
Al 
Al 
A3 
Al 
A3 
A2 
Al 
Al 
A2 
A2 
Al 
A2 
A3 
Al 
Al 
A3 
A2 
A3 
Al 
A2 
Al 
A2 
A2 
A3 
Al 
Al 
A3 
2 
Al 
Al 
A2 
Isolate 
NUIII 
Pt I 
Num I 
I I 
I I 
I I 
6 26 
6 29 
6 30 
6 28 
4 16 
6 27 
16 
5 22 
4 18 
4 19 
5 23 
5 21 
3 13 
7 34 
11 
3 15 
2 11 
14 
5 24 
15 
2 12 
7 31 
4 17 
5 25 
7 33 
12 
2 7 
2 8 
13 
4 20 
2 9 
3 14 
2 10 
7 32 
Dendrogram using Average Linkage (Between Groups) 
Resealed Distance Cluster Combine 
0 5 10 15 20 25 
+---------+---------+---------+---------+---------+ 
-+ 
-+-+ 
-+ +---------------------------------------------+ 
---+ 
---------------+-----------------------i I 
------------e-e+ I 
-t-t I I 
-+ I I 
-+ t-e---+ I 
-+ I I I 
-t-t +-------------+ I J 
-+ I 
I 
1 
---+-D-e-+ I I 
---+ I I I 
-t I t---------t 
-+---+ I 
-+ I t-------t I 
-t-t t---------t I 
-+ +-+ I I 
---t 1 
-t-t ( I I 
-+ I I I 
-t +-+ I I I 
-+ I +-e---e-+ I I 
-t-t I +-------+ 
-t 
-+ I 
I 
I 
-t-------t I 
-t I I I 
-t t-----t I 
-t-t I 
-+ +--em-+ 
-e-f. 
--,-------------L--------------+ 
FIG. 2. Genetic relatedness of Burkholderia cepacia isolates obtained on serial cultures from seven patients 
(l-7) followed at center D based on isolates’ chromosomal DNA pattern (DNA). The dendrogram also shows 
distance between B. cepacia isolates from center D, based on bacterial cell wall fatty acid methyl ester 
(FAME) profile. 
isolates obtained from serial cultures of seven 
patients. The present DNA data corroborate the 
observations of others where ribotyping of serial B. 
cepacia isolates of chronically colonised patients 
revealed that patients harbor a single strain of B. 
cepacia for prolonged periods (5,13). Furthermore, 
Larsen et al. observed that even though the isolates 
were identical on ribotyping, there was marked phe- 
notypic variability iin B. cepucia isolates from one 
patient (5). Morphologically dissimilar isolates from 
one culture had different DNA restriction patterns. 
The presence of phenotypic variability in the absence 
of ribotype differences was attributed to differential 
gene expression by the isolates (5). Steinbach et al., 
who studied serial B. cepacia isolates by PFGE, also 
reported that a single B. cepacia strain persisted for 
years, -as well as post-transplant, in CF patients (23). 
Comparing the FAME profiles and the DNA fin- 
gerprinting of the serial isolates from seven patients 
demonstrates ,&fferences in these typing techniques. 
TWQ isolates from center E demonstrated DNA pat- 
ter.n B .and yet a sigmficant distance on dendrogram 
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in their FAME profiles. This observation suggests 
that cellular fatty acid composition may also be 
related to differential gene expression. Clearly, 
additional studies evaluating the correlation of 
FAME profiles and DNA pattern correlations are 
necessary to understand the relationship between 
DNA relatedness and cellular fatty acid composition 
of the isolates. 
The data reported here and observations of others 
have shown that there is significant relatedness in B. 
cepucia isolates among patients from a CF center 
(7,9,12,18,24), although Steinbach et al., in their 
study of 17 clinic patients, found that each patient 
was infected with a distinct strain (23). Smith et al. 
reported evidence of person-to-person transmission 
of B. cepucia outside the hospital environment when 
they investigated an epidemic of B. cepacia in adult 
patients in a CF unit (7). Fisher et al. studied B. 
cepacia isolates at two children’s hospitals and from 
the patients’ environments, and reported that 
ribotype R3 predominated among isolates from all 
their sources. They suggested that patients may be 
acquiring B. cepuciu isolates from their environment 
(12). Nosocomial outbreaks of B. cepaciu have also 
been reported from CF patients (18,24). Therefore, 
adequate methods to determine strain relatedness 
are also needed in other hospital epidemiology 
investigations. The present data support observations 
that B. cepacia isolates in CF centers are closely 
related. Efforts to decrease person-to-person or 
environment-to-person acquisition may influence 
the spread of B. cepaciu colonisation among suscep- 
tible patients, as suggested by several investigators 
(6,23. 
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